Dr. Kyong Park is an Assistant Professor in the Department of Internal Medicine at Thomas Jefferson University in Havertown, PA. He has conducted research on the effects of antiviral therapy on the survival of patients with HBV-associated hepatocellular carcinoma (HCC) following local tumor ablation. His publications in Cancer Medicine have contributed to the understanding of treatment outcomes for this specific type of cancer.
Dr. Park's work focuses on the intersection of antiviral therapy and tumor ablation in patients with HBV-associated HCC. His research findings have provided valuable insights into the long-term effects of these treatment approaches on patient survival. Through his contributions to the field, Dr. Park has advanced our understanding of the management and treatment options for individuals with this type of cancer.
Generated from the website